论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
转铁蛋白和叶酸共修饰、加载蟾蜍灵的纳米脂质体:抗癌活性的制备、表征和应用
Authors Chen Q, Liu J
Received 1 June 2018
Accepted for publication 2 August 2018
Published 5 October 2018 Volume 2018:13 Pages 6009—6018
DOI https://doi.org/10.2147/IJN.S176012
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Cristina Weinberg
Peer reviewer comments 2
Editor who approved publication: Dr Linlin Sun
Aim: The aim of this study was to prepare transferrin (Tf) and folic acid (FA) co-modified bufalin (BF) liposomes for lung cancer treatment.
Method: In this study, (FA+Tf) BF-LPs were prepared using the high-pressure homogenization method.
Results: The EE% and DL% of prepared LPs were 82.3% and 10.7%, respectively, and the mean diameter was 120.4 nm from three batches. In vitro release showed that the release of BF from (FA+Tf) BF-LPs was slow with burst effects at an early stage. In vitro cytotoxicity assay showed that (FA+Tf) BF-LPs had a superior antiproliferative effect on A549 cells. An in vivo imaging study indicated that (FA+Tf) BF-LPs had obvious targeting characteristics on subcutaneous tumor, with the potential to actively deliver drugs to tumor tissues. In terms of the in vivo antitumor activity, (FA+Tf) BF-LPs treated mice showed a significantly suppressed tumor growth and no systemic toxicity in the body.
Conclusion: Through this study, it was found that the Tf and FA co-modified BF could be a very promising lung target preparation.
Keywords: transferrin, folic acid, liposomes, bufalin, in vivo imaging, antitumor activity